U.S. government agencies have implemented enhanced health screening for travelers arriving at Washington Dulles International Airport from specific African countries [1].
The measure follows the emergence of a rare Ebola virus strain for which no approved vaccine exists [3]. Because the virus lacks a preventative medical countermeasure, the Centers for Disease Control and Prevention (CDC) and the Department of State are prioritizing early detection to prevent a domestic outbreak [1, 2].
Screening requirements apply to travelers who have visited the Democratic Republic of Congo, Uganda, or South Sudan within the past three weeks [1, 4]. These countries are the primary locations of the current outbreak [4]. While some reports list only Congo and Uganda, other official summaries include South Sudan in the high-risk zone [1, 5].
Officials are monitoring passengers for symptoms as they enter the U.S. to contain the spread of the rare strain [1]. The World Health Organization said the situation in Congo is a global health emergency [3].
U.S. agencies are also working to relocate affected Americans from the region [2]. The lack of a vaccine increases the risk associated with travel from these areas, making stringent airport checkpoints the primary line of defense against the virus [3, 4].
“No approved vaccine exists for the rare Ebola strain”
The implementation of enhanced screening at a major international hub like Dulles indicates a high level of concern regarding the transmissibility of this specific Ebola strain. Because there is no vaccine to protect travelers or healthcare workers, the U.S. government is relying on traditional quarantine and monitoring protocols to manage the risk of importation.
